Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


暴雪加速器vp-暴雪vp(永久免费)加速器下载-暴雪加速器官网-暴雪加速器vp

July 31, 2025 - Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results July 7, 2025 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2025 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

暴雪加速器vp-暴雪vp(永久免费)加速器下载-暴雪加速器官网-暴雪加速器vp

暴雪加速器vp-暴雪vp(永久免费)加速器下载-暴雪加速器官网-暴雪加速器vp

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

暴雪加速器vp-暴雪vp(永久免费)加速器下载-暴雪加速器官网-暴雪加速器vp

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
安卓翻软件墙下载百度云  苹果好用的免费加速器  苹果加速器免费加速  奇点加速器  vp 加速器下载  黑豹加速器电脑版  谷歌梯子教程